Sequenom, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

SQNM 4.28 -0.06 (-1.38%)
price chart
Sequenom, Inc. (NASDAQ:SQNM) revenue is starting to rise.
(Yahoo Finance contributor)Sequenom, Inc. (NASDAQ:SQNM) is a poster child for the dotcom bust. The stock debuted after the February 2000 IPO at 53.25 and rose to over $143 per share the next month, before a full on implosion to under $1 before the end ...
Wall Street Has $4.94 Price Target on Sequenom, Inc. (NASDAQ:SQNM)  The Markets Daily
Why Sequenom, Inc. Stock Scorched 23% Higher in December
What: Shares of Sequenom (NASDAQ: SQNM ) , a life sciences company focused on developing genomic and genetic analysis solutions and diagnostics, soared by 23% in December, based on data from S&P Capital IQ, after settling a long-standing legal ...
Why Sequenom, Inc. Stock Skyrocketed
What: Shares of Sequenom (NASDAQ: SQNM ) , a developer of genetic analysis solutions and molecular diagnostic tests, skyrocketed by as much as 37% after announcing that it had ended a long-standing patent dispute with Illumina (NASDAQ: ILMN ) .
Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual ...  Business Wire (press release)
Sequenom climbs after genetic analysis company ends patent dispute with ...  Fox Business
Related articles »  
Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2014 Financial ...
SAN DIEGO, Feb. 19, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a leading molecular diagnostics company, today announced it will report financial results for the fourth quarter and full year 2014 after closing of the NASDAQ Global Market on ...
Sequenom Inc. (SQNM) is Trading Higher on Unusual Volume for April 08
Sequenom Inc. (SQNM) experienced unusually high volume on Apr. 08, as the stock gained 1.53% to a closing price of $3.98. The stock saw 1.93 million shares trade hands over the course of the day on 5,737 trades.
The Liquid Biopsy Will Boost Revenue For Sequenom And Illumina
Sequenom, Inc. (NASDAQ:SQNM) is a $450 million clinical laboratory company based in San Diego, California. Sequenom's main revenue generating assay is a clinical test that detects chromosomal abnormalities in a fetus using only a maternal serum ...
Sequenom, Inc. v. The Board of Trustees of The Leland Stanford Junior ...
In its Final Written Decision, the Board found that Petitioner had not shown by a preponderance of the evidence any of challenged claims 1-17 of the '415 patent was unpatentable.
Related articles »  
Sequenom, Inc. (NASDAQ:SQNM) reported profit in the fiscal fourth quarter results
Sequenom, Inc., a life sciences company, provides genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets in the United States and internationally.
Sequenom Reports 2014 Final And Fourth Quarter Financials  PR Newswire (press release)
Sequenom (SQNM) Beats Q4 EPS Expectations  Wall Street Pit
Sequenom Inc. (SQNM) Hits New 52-week High During April 15 Session
Sequenom Inc. is also a component of the Russell 2000 Index, which is an invaluable tool for any small-cap investor. Consisting of the smaller 2,000 publicly traded companies of the 3,000 largest companies in America by market cap (which combine to ...
Sequenom, Inc. Announces Participation At The 33rd Annual J.P. Morgan ...
SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a leading molecular diagnostics company, today announced the Company's participation at the 2015 J.P.
Related articles »